Indrayani Biotech Balance Sheet Health
Financial Health criteria checks 2/6
Indrayani Biotech has a total shareholder equity of ₹762.7M and total debt of ₹1.1B, which brings its debt-to-equity ratio to 147.5%. Its total assets and total liabilities are ₹2.4B and ₹1.6B respectively. Indrayani Biotech's EBIT is ₹222.1M making its interest coverage ratio 2.2. It has cash and short-term investments of ₹302.5M.
Key information
147.5%
Debt to equity ratio
₹1.13b
Debt
| Interest coverage ratio | 2.2x |
| Cash | ₹302.52m |
| Equity | ₹762.66m |
| Total liabilities | ₹1.59b |
| Total assets | ₹2.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 526445's short term assets (₹1.4B) exceed its short term liabilities (₹870.7M).
Long Term Liabilities: 526445's short term assets (₹1.4B) exceed its long term liabilities (₹716.9M).
Debt to Equity History and Analysis
Debt Level: 526445's net debt to equity ratio (107.9%) is considered high.
Reducing Debt: Insufficient data to determine if 526445's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 526445's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 526445's interest payments on its debt are not well covered by EBIT (2.2x coverage).